Literature DB >> 25365788

Distant polypharmacology among MLP chemical probes.

Albert A Antolín1, Jordi Mestres.   

Abstract

Small molecules are essential tool compounds to probe the role of proteins in biology and advance toward more efficient therapeutics. However, they are used without a complete knowledge of their selectivity across the entire proteome, at risk of confounding their effects due to unknown off-target interactions. Current state-of-the-art computational approaches to predicting the affinity profile of small molecules offer a means to anticipate potential nonobvious selectivity liabilities of chemical probes. The application of in silico target profiling on the full set of chemical probes from the NIH Molecular Libraries Program (MLP) resulted in the identification of biologically relevant in vitro affinities for proteins distantly related to the primary targets of ML006, ML123, ML141, and ML204, helping to lower the risk of their further use in chemical biology.

Mesh:

Substances:

Year:  2014        PMID: 25365788     DOI: 10.1021/cb500393m

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  11 in total

1.  Screening-based translation of public research encounters painful problems.

Authors:  Jonathan B Baell
Journal:  ACS Med Chem Lett       Date:  2015-02-09       Impact factor: 4.345

Review 2.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

3.  Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes.

Authors:  Rakesh Kumar; Neha Yadav; Rodolfo Lavilla; Daniel Blasi; Jordi Quintana; José Manuel Brea; María Isabel Loza; Jordi Mestres; Mamta Bhandari; Ritu Arora; Rita Kakkar; Ashok K Prasad
Journal:  Mol Divers       Date:  2017-04-25       Impact factor: 2.943

Review 4.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

5.  Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels.

Authors:  Yingmin Zhu; Yungang Lu; Chunrong Qu; Melissa Miller; Jinbin Tian; Dhananjay P Thakur; Jinmei Zhu; Zixin Deng; Xianming Hu; Meng Wu; Owen B McManus; Min Li; Xuechuan Hong; Michael X Zhu; Huai-Rong Luo
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

6.  Activity-Independent Discovery of Secondary Metabolites Using Chemical Elicitation and Cheminformatic Inference.

Authors:  Sheila M Pimentel-Elardo; Dan Sørensen; Louis Ho; Mikaela Ziko; Stephanie A Bueler; Stella Lu; Joe Tao; Arvin Moser; Richard Lee; David Agard; Greg Fairn; John L Rubinstein; Brian K Shoichet; Justin R Nodwell
Journal:  ACS Chem Biol       Date:  2015-09-18       Impact factor: 5.100

7.  Parallel worlds of public and commercial bioactive chemistry data.

Authors:  Christopher A Lipinski; Nadia K Litterman; Christopher Southan; Antony J Williams; Alex M Clark; Sean Ekins
Journal:  J Med Chem       Date:  2014-12-04       Impact factor: 7.446

Review 8.  Polypharmacology in Precision Oncology: Current Applications and Future Prospects.

Authors:  Albert A Antolin; Paul Workman; Jordi Mestres; Bissan Al-Lazikani
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

9.  Dual Inhibitors of PARPs and ROCKs.

Authors:  Albert A Antolín; Jordi Mestres
Journal:  ACS Omega       Date:  2018-10-05

10.  Closing the Gap Between Therapeutic Use and Mode of Action in Remedial Herbs.

Authors:  Joaquim Olivés; Jordi Mestres
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.